rs344454

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.98-69929G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.264 in 152,050 control chromosomes in the GnomAD database, including 13,762 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 13762 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0560

Publications

5 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.79 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.98-69929G>A intron_variant Intron 1 of 23 ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4
CNTNAP2XM_017011950.3 linkc.98-69929G>A intron_variant Intron 1 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.98-69929G>A intron_variant Intron 1 of 23 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1
CNTNAP2ENST00000625365.2 linkc.98-69929G>A intron_variant Intron 2 of 3 5 ENSP00000485955.1 A0A0D9SES4
CNTNAP2ENST00000637150.1 linkn.27-69929G>A intron_variant Intron 1 of 8 5

Frequencies

GnomAD3 genomes
AF:
0.264
AC:
40047
AN:
151932
Hom.:
13705
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.797
Gnomad AMI
AF:
0.0318
Gnomad AMR
AF:
0.130
Gnomad ASJ
AF:
0.124
Gnomad EAS
AF:
0.126
Gnomad SAS
AF:
0.0818
Gnomad FIN
AF:
0.0203
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.0422
Gnomad OTH
AF:
0.230
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.264
AC:
40157
AN:
152050
Hom.:
13762
Cov.:
32
AF XY:
0.257
AC XY:
19109
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.797
AC:
33065
AN:
41466
American (AMR)
AF:
0.130
AC:
1980
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.124
AC:
430
AN:
3460
East Asian (EAS)
AF:
0.126
AC:
650
AN:
5170
South Asian (SAS)
AF:
0.0813
AC:
392
AN:
4824
European-Finnish (FIN)
AF:
0.0203
AC:
215
AN:
10602
Middle Eastern (MID)
AF:
0.153
AC:
45
AN:
294
European-Non Finnish (NFE)
AF:
0.0422
AC:
2868
AN:
67972
Other (OTH)
AF:
0.229
AC:
483
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
666
1332
1997
2663
3329
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.114
Hom.:
6765
Asia WGS
AF:
0.144
AC:
501
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
4.7
DANN
Benign
0.23
PhyloP100
0.056
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs344454; hg19: chr7-146401434; API